Abilify (aripiprazole) Briefing Materials
For the September 12, 2017 meeting of the FDA’s Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
Briefing Materials
- Abilify Safety and Utilization Review
- Abilify Labeling, 2/2017
- Abilify Clinical Review
- Abilify Statistical Review